The Products of the Herpes Simplex Virus Type 1 Immediate-early US1/US1.5 Genes Downregulate Levels of S-phase-specific Cyclins and Facilitate Virus Replication in S-phase Vero Cells

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2006 Mar 31

PMID 16571817

Citations 29

Authors

Joseph S Orlando

Todd L Astor

Scott A Rundle

Priscilla A Schaffer

Affiliations

Soon will be listed here.

Abstract

Herpes simplex virus type 1 ICP22-/U(S)1.5- mutants initiate viral gene expression in all cells; however, in most cell types, the replication process stalls due to an inability to express gamma2 late proteins. Although the function of ICP22/U(S)1.5 has not been established, it has been suggested that these proteins activate, induce, or repress the activity of cellular proteins during infection. In this study, we hypothesized that cell cycle-associated proteins are targets of ICP22/U(S)1.5. For this purpose, we first isolated and characterized an ICP22-/U(S)1.5- mutant virus, 22/n199. Like other ICP22-/U(S)1.5- mutants, 22/n199 replicates in a cell-type-specific manner and fails to induce efficient gamma2 late gene expression in restrictive cells. Although synchronization of restrictive human embryonic lung cells in each phase of the cell cycle did not overcome the growth restrictions of 22/n199, synchronization of permissive Vero cells in S phase rendered them less able to support 22/n199 plaque formation and replication. Consistent with this finding, expression of cellular S-phase cyclins was altered in an ICP22/U(S)1.5-dependent manner specifically when S-phase Vero cells were infected. Collectively, these observations support the notion that ICP22/U(S)1.5 deregulates the cell cycle upon infection of S-phase permissive cells by altering expression of key cell cycle regulatory proteins either directly or indirectly.

Citing Articles

The opportunities and challenges of epigenetic approaches to manage herpes simplex infections.

Saddoris S, Schang L Expert Rev Anti Infect Ther. 2024; 22(12):1123-1142.

PMID: 39466139 PMC: 11634640. DOI: 10.1080/14787210.2024.2420329.

A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection.

Domanico L, Dunn G, Kobiler O, Taylor M J Virol. 2024; 98(5):e0003224.

PMID: 38651900 PMC: 11092338. DOI: 10.1128/jvi.00032-24.

A Revision of Herpes Simplex Virus Type 1 Transcription: First, Repress; Then, Express.

Dunn L, Birkenheuer C, Baines J Microorganisms. 2024; 12(2).

PMID: 38399666 PMC: 10892140. DOI: 10.3390/microorganisms12020262.

Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infection.

Samer C, McWilliam H, McSharry B, Velusamy T, Burchfield J, Stanton R iScience. 2024; 27(2):108801.

PMID: 38303725 PMC: 10831258. DOI: 10.1016/j.isci.2024.108801.

The HSV-1 ICP22 protein selectively impairs histone repositioning upon Pol II transcription downstream of genes.

Djakovic L, Hennig T, Reinisch K, Milic A, Whisnant A, Wolf K Nat Commun. 2023; 14(1):4591.

PMID: 37524699 PMC: 10390501. DOI: 10.1038/s41467-023-40217-w.

References

Schaffer P, Aron G, Biswal N, Benyesh-Melnick M . Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology. 1973; 52(1):57-71. DOI: 10.1016/0042-6822(73)90398-x. View

Balliet J, Min J, Cabatingan M, Schaffer P . Site-directed mutagenesis of large DNA palindromes: construction and in vitro characterization of herpes simplex virus type 1 mutants containing point mutations that eliminate the oriL or oriS initiation function. J Virol. 2005; 79(20):12783-97. PMC: 1235857. DOI: 10.1128/JVI.79.20.12783-12797.2005. View

Goldin A, Sandri-Goldin R, Levine M, Glorioso J . Cloning of herpes simplex virus type 1 sequences representing the whole genome. J Virol. 1981; 38(1):50-8. PMC: 171125. DOI: 10.1128/JVI.38.1.50-58.1981. View

Post L, Roizman B . A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell. 1981; 25(1):227-32. DOI: 10.1016/0092-8674(81)90247-6. View

Sears A, Halliburton I, Meignier B, Silver S, Roizman B . Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J Virol. 1985; 55(2):338-46. PMC: 254938. DOI: 10.1128/JVI.55.2.338-346.1985. View

Ackermann M, Sarmiento M, Roizman B . Application of antibody to synthetic peptides for characterization of the intact and truncated alpha 22 protein specified by herpes simplex virus 1 and the R325 alpha 22- deletion mutant. J Virol. 1985; 56(1):207-15. PMC: 252507. DOI: 10.1128/JVI.56.1.207-215.1985. View

DeLuca N, McCarthy A, Schaffer P . Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol. 1985; 56(2):558-70. PMC: 252613. DOI: 10.1128/JVI.56.2.558-570.1985. View

Whyte P, Buchkovich K, Horowitz J, Friend S, Raybuck M, Weinberg R . Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature. 1988; 334(6178):124-9. DOI: 10.1038/334124a0. View

DeCaprio J, Ludlow J, Figge J, Shew J, Huang C, Lee W . SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 1988; 54(2):275-83. DOI: 10.1016/0092-8674(88)90559-4. View

10.

Whyte P, Williamson N, Harlow E . Cellular targets for transformation by the adenovirus E1A proteins. Cell. 1989; 56(1):67-75. DOI: 10.1016/0092-8674(89)90984-7. View

11.

Dyson N, Howley P, Munger K, Harlow E . The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989; 243(4893):934-7. DOI: 10.1126/science.2537532. View

12.

Bagchi S, Raychaudhuri P, Nevins J . Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system. Proc Natl Acad Sci U S A. 1989; 86(12):4352-6. PMC: 287267. DOI: 10.1073/pnas.86.12.4352. View

13.

Cai W, Schaffer P . Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol. 1989; 63(11):4579-89. PMC: 251091. DOI: 10.1128/JVI.63.11.4579-4589.1989. View

14.

Cai W, Schaffer P . A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1. J Virol. 1991; 65(8):4078-90. PMC: 248840. DOI: 10.1128/JVI.65.8.4078-4090.1991. View

15.

Daksis J, Preston C . Herpes simplex virus immediate early gene expression in the absence of transinduction by Vmw65 varies during the cell cycle. Virology. 1992; 189(1):196-202. DOI: 10.1016/0042-6822(92)90695-l. View

16.

Diaz J, Simonin D, Masse T, Deviller P, Kindbeiter K, Denoroy L . The herpes simplex virus type 1 US11 gene product is a phosphorylated protein found to be non-specifically associated with both ribosomal subunits. J Gen Virol. 1993; 74 ( Pt 3):397-406. DOI: 10.1099/0022-1317-74-3-397. View

17.

Poffenberger K, Raichlen P, HERMAN R . In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant. Virus Genes. 1993; 7(2):171-86. DOI: 10.1007/BF01702397. View

18.

Yeh L, Schaffer P . A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J Virol. 1993; 67(12):7373-82. PMC: 238201. DOI: 10.1128/JVI.67.12.7373-7382.1993. View

19.

Advani S, Brandimarti R, Weichselbaum R, Roizman B . The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes. J Virol. 1999; 74(1):8-15. PMC: 111507. View

20.

Ehmann G, McLean T, Bachenheimer S . Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells. Virology. 2000; 267(2):335-49. DOI: 10.1006/viro.1999.0147. View